6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY
Amended material disclosure
To Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager
Announces 1-for-30 Reverse Stock Split
Abpro Holdings, Inc. Executes 1-for-30 Reverse Stock Split Effective October ...
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Abpro Holdings, Inc. Annual Meeting - Proposals Submitted for Vote
News, Material Contracts
Q2
Q1
FY 2024
Notice of Late Filing for Annual Report
Q3
Notice of Late Filing for Quarterly Report
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Post-Effective Amendment
Post-Effective Amendment to Registration Statement
Submission Upload
Correspondence
S-1MEF